ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,753Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 783

$1.09M Total Retail Price of All Prescriptions

Rank: 40 out of 783

789 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 789 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 789 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,163 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,028 705 S3 1 2
LEVOTHYROXINE SODIUM 784 711 2 1
AMLODIPINE BESYLATE 432 391 3 5
FUROSEMIDE 423 390 4 7
SIMVASTATIN 420 376 5 3
METFORMIN HCL 393 283 6 8
LISINOPRIL 306 267 7 4
ZOLPIDEM TARTRATE 304 243 8 23
OMEPRAZOLE 280 228 9 6
WARFARIN SODIUM 232 195 10 10
GLIMEPIRIDE 216 182 11 34
LOVASTATIN 202 184 12 58
METOPROLOL TARTRATE 191 178 13 9
PANTOPRAZOLE SODIUM 183 156 14 30
DONEPEZIL HCL 171 167 15 24
GABAPENTIN 164 102 16 15
SERTRALINE HCL 139 113 17 22
ACETAMINOPHEN-CODEINE 137 117 S3 18 144
PREDNISONE 134 121 19 36
AMLODIPINE BESYLATE-BENAZEPRIL 130 124 20 83
ALENDRONATE SODIUM 121 114 21 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 107 22 33
FAMOTIDINE 116 110 23 55
TRAMADOL HCL 113 101 24 20
ATORVASTATIN CALCIUM 109 89 25 11
CLOPIDOGREL 108 94 26 29
NEXIUM 107 96 27 28
CRESTOR 107 100 27 27
LOSARTAN POTASSIUM 107 98 27 18
METOPROLOL SUCCINATE 105 99 30 13
NATEGLINIDE 104 83 31 274
ATENOLOL 104 83 31 17
AMITRIPTYLINE HCL 102 58 R 33 77
AZITHROMYCIN 98 73 34 41
CLONAZEPAM 96 93 35 369
CARISOPRODOL 96 37 R 35 168
CYMBALTA 94 81 37 35
POTASSIUM CHLORIDE 92 91 38 16
GEMFIBROZIL 89 76 39 105
TAMSULOSIN HCL 86 66 40 26
LOSARTAN-HYDROCHLOROTHIAZIDE 86 74 40 53
MELOXICAM 85 74 42 37
NIFEDIPINE ER 85 85 42 135
BENAZEPRIL HCL 84 80 44 85
OXYCODONE HCL-ACETAMINOPHEN 84 40 S2 44 86
ALPRAZOLAM 83 69 46 145
JANUVIA 82 58 47 73
DIOVAN 80 75 48 49
VITAMIN D2 78 78 49 383
DOXAZOSIN MESYLATE 78 74 49 87
DIGOXIN 78 74 49 61
CIPROFLOXACIN HCL 77 67 52 62
DIOVAN HCT 74 74 53 94
ALLOPURINOL 74 73 53 31
PROAIR HFA 71 36 55 56
PLAVIX 70 61 56 51
LANSOPRAZOLE 69 50 57 177
FENTANYL 68 20 S2 58 65
BENICAR 66 66 59 182
NAMENDA 65 65 60 32
KLOR-CON M20 65 58 60 48
CITALOPRAM HBR 65 60 60 19
BUPROPION HCL 61 38 63 338
CLONIDINE HCL 61 49 63 60
FLUOXETINE HCL 59 28 65 45
METOLAZONE 58 47 66 186
HYDROCHLOROTHIAZIDE 57 52 67 12
METRONIDAZOLE 57 51 67 229
CYCLOBENZAPRINE HCL 55 18 R 69 63
PROMETHAZINE-CODEINE 55 53 R 69 430
CELEBREX 55 50 69 93
POLYETHYLENE GLYCOL 3350 55 41 69 43
TRICOR 53 41 73 134
SPIRIVA 53 43 73 59
LEVOFLOXACIN 52 36 75 75
PRAVASTATIN SODIUM 52 52 75 14
AZOR 51 51 77 287
CARBIDOPA-LEVODOPA 51 37 77 88
GLIPIZIDE 51 49 77 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.